The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
Official Title: Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment . Geriatric Oncology Protocol in Aquitaine Country.
Study ID: NCT00210249
Brief Summary: Incidence of cancer in 75+ years old is 16,500 new cases per year, more than fifty percent of people with cancerThey are very few therapeutic trials dedicated. Oncologists hesitate to treat them because they are either afraid of inducing toxicity or of breaking down quality of life. Consequently, we decided to launch a protocol with both oncologists and geriatricians which principal aim is to find out if geriatric assessment data can help to better predict for chemotherapy toxicity, loss of autonomy and survival. We plan to accrue 360 patients diagnosed for cancer, including digestive, pulmonary, prostate, lymphoma, bladder, ovary cancer for whom first-line chemotherapy is planned. Patients are initially classified according to usual methods of medical oncology practice into three groups: patients who can receive standard treatment, reduced standard treatment or treatment adapted to the frail condition. Around Aquitaine, , we organised seven teams composed of one geriatrician and one nurse. Two kind of teams were activated: one which cover ten treatment sites in Bordeaux area and six sedentary teams which worked half a day a week in designated hospitals . Geriatric evaluation included test of cognitive functions (MMS), nutritional status (MNA), co-morbidity (CIRS-G), mobility (Get up and Go), activities (ADL;IADL), quality of life (QLQ-C30), depression (GDS-15) and Lachs-Balducci screening. Patients have four geriatric evaluations : before treatment, day 1 cycle 2, day 1 cycle 4, day 1 cycle 7 and/or end of chemotherapy. Since September 2002, 177 patients have been included, 112 have finished: 47.3% have received four evaluations, 16.1% died before the end of protocol, 14.3% stopped because they were in progression and changed their treatment, 11.6% met administrative problem that didn't allow all evaluations, 7.1% declined after inclusion and 3.6% finished their treatment before. The following results have been obtained: before treatment, 73% of these patients were at risk of undernutrition (MNA\< 23.5), about 1/3 had one or more inability or a risk of falls (38% IADL\<6, 29% get up and go\>20seconds, 27% ADL\>1, 34% PS\<1), 28% of them had altered cognitive functions (MMS\<24), 29% were depressive (GDS-15\>6), 25% thought they had poor quality of life (QLQ-C30\<4). Protocol will be closed in September 2005.
Detailed Description:
Minimum Age: 70 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centre de radiothérapie d'Agen, Agen, , France
Centre Hospitalier Universitaire d'Agen, Agen, , France
Clinique Esquirol Saint Hilaire, Agen, , France
Centre Hospitalier Universitaire de Bayonne, Bayonne, , France
Centre Hospitalier de la Côte Basque, Bayonne, , France
Clinique Saint Etienne du Pays Basque, Bayonne, , France
Clinique Tivoli, Bordeaux, , France
Centre Hospitalier Universitaire de Bordeaux, Bordeaux, , France
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest, Bordeaux, , France
Centre Hospitalier Universitaire de Dax, Dax, , France
Hopital Sub-Urbain du Bouscat, Le Bouscat, , France
Hôpital Robert Boulin, Libourne, , France
Centre Hospitalier Universitaire de Mont de Marsan, Mont de Marsan, , France
Centre Hospitalier Universitaire de Pau, Pau, , France
Centre Hospitalier Universitaire de Perigueux, Perigueux, , France
Clinique Francheville, Perigueux, , France
Maison de Santé Protestante Bagatelle, Talence, , France
Centre Hospitalier Universitaire de Villeneuve sur Lot, Villeneuve sur Lot, , France
Name: Pierre SOUBEYRAN, MD, PhD
Affiliation: Institut Bergonié
Role: PRINCIPAL_INVESTIGATOR